Cognition Therapeutics Inc. (CGTX): Investing has never been easier

At the end of the latest market close, Cognition Therapeutics Inc. (CGTX) was valued at $1.97. In that particular session, Stock kicked-off at the price of $1.914 while reaching the peak value of $2.02 and lowest value recorded on the day was $1.76. The stock current value is $1.88.Recently in News on August 9, 2022, Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update. Ongoing Patient Dosing in SHIMMER Study for DLB and SHINE Study for Alzheimer’s DiseasePositive Preliminary Data for Dry AMD Program Presented at ARVO 2022Proteomics Data from SPARC read out at AAIC. You can read further details here

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cognition Therapeutics Inc. shares are logging -86.38% during the 52-week period from high price, and 25.33% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.50 and $13.80.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 62621 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Cognition Therapeutics Inc. (CGTX) recorded performance in the market was -70.25%, having the revenues showcasing -24.50% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 44.35M, as it employees total of 19 workers.

Market experts do have their say about Cognition Therapeutics Inc. (CGTX)

During the last month, 2 analysts gave the Cognition Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.3719, with a change in the price was noted -1.30. In a similar fashion, Cognition Therapeutics Inc. posted a movement of -40.88% for the period of last 100 days, recording 341,734 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CGTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Cognition Therapeutics Inc. (CGTX)

Raw Stochastic average of Cognition Therapeutics Inc. in the period of last 50 days is set at 6.99%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.64%. In the last 20 days, the company’s Stochastic %K was 5.93% and its Stochastic %D was recorded 4.29%.

Bearing in mind the latest performance of Cognition Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -70.25%. The shares increased approximately by -8.74% in the 7-day charts and went up by -47.78% in the period of the last 30 days. Common stock shares were lifted by -24.50% during last recorded quarter.